Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 123 results found. Search for [ COVID-19 vaccine Gamaleya ]

Results 1 to 21 of 123
BusinessToday.In
June 17, 2021
The two hospitals that are participating in the pilot roll-out of Sputnik V are Fortis Memorial Research Institute, Gurugram and Fortis Hospital, Mohali


BusinessToday.In
New Delhi, June 17, 2021
Microsoft Corp on Wednesday named Chief Executive Officer Satya Nadella as its new chairman, in place of John Thompson; One97 Communications, the parent company of Paytm has roped in some of the most influential investment bankers for its proposed initial public offering (IPO); Prime Minister Narendra Modi, during the 5th edition of VivaTech summit, said on Wednesday that COVID-19 has put many conventional methods to test and that innovation is the only way out when convention fails. Watch this and more on News Blast.Also Read: Another vaccine to be rolled out soon! Serum plans to launch Covovax by Sept


Rashi Bisaria
New Delhi, June 17, 2021
COVID-19: Is there a 'Moscow strain'? Sputnik V vaccine maker believes soThere may be a new mutant of coronavirus in Russia's capital Moscow, so-called \"Moscow strain\", which may be behind the recent spike in cases in the city. The Gamaleya National Center of Epidemiology and Microbiology, which developed COVID-19 vaccine Sputnik V, is studying the effectiveness of the jab against the new strain, as per Russian state-owned news agency RIA Novosti.Microsoft CEO Satya Nadella named as chair...


BusinessToday.In
June 16, 2021
The Gamaleya National Center of Epidemiology and Microbiology, which developed COVID-19 vaccine Sputnik V, is studying the effectiveness of the jab against the new strain.


Shailendra Shukla
New Delhi, June 5, 2021
'Publicity': Delhi HC junks Juhi Chawla's suit against 5G; imposes Rs 20-lakh fineThe Delhi High Court on Friday dismissed the lawsuit by actress Juhi Chawla against the implementation of 5G network technology in the country. The court ruled the plea was filed to gain \"publicity\" and that the plaintiffs, Chawla and two others, have abused the process of law. The Delhi High Court has imposed a fine of Rs 20 lakh on the plaintiffs. After the court pronounced the judgement, Chawla's counsel s...


BusinessToday.In
June 4, 2021
Pune-based SII has partnered with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, in Russia for developing Sputnik V COVID-19 vaccine in India at its licensed facility in Hadapsar


PTI
May 24, 2021
As announced in April, the Russian Direct Investment Fund (RDIF) - which markets the vaccine internationally, and Panacea Biotec agreed to produce 100 million doses per year of Sputnik V in India


BusinessToday.In
May 24, 2021
First batch produced at Panacea Biotec's facilities at Baddi will be shipped to the Gamaleya Centre for quality control. Full-scale production of the vaccine is due to start soon


BusinessToday.In
May 17, 2021
Dr Reddy's Laboratories CEO - Branded Markets (India & Emerging Markets) MV Ramana said the two entities are working to scale up the pilot and take the vaccine to other cities.


Manoj Sharma
May 17, 2021
The current vaccine makers, Serum Institute and Bharat Biotech, alone won't be able to meet the demand. There are other players too in vaccine production, and they should be able to cater to the demand in the months ahead


Vivek Dubey
May 6, 2021
\"The cost of the Sputnik Light vaccine globally will be less than $10 [around Rs 730], while it has simple storage requirements, at 2-8 degrees Celsius, which provide for easy logistics\"


BusinessToday.In
May 1, 2021
Developed by Russia's Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V was approved by Indian drug regulator last month.


Reuters
April 27, 2021
Anvisa's five-strong board voted unanimously not to approve the Russian vaccine after technical staff had highlighted \"inherent risks\" and \"serious\" defects, citing a lack of information guaranteeing its safety, quality and effectiveness


BusinessToday.In
April 25, 2021
The Hyderabad-based vaccine manufacturer has submitted updated accelerated and real-time stability data of Coaxin along with the justification for the extension of shelf life


BusinessToday.In
April 13, 2021
India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year


BusinessToday.In
New Delhi, April 12, 2021
Russia's Sputnik V COVID-19 vaccine, with an effectiveness of 91.6 per cent, has been approved for restricted use in India, sources within the drug regulator's office confirmed the development on Monday. The approval to the vaccine was given based on 'very strong immunogenicity data'. Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine demonstrated an efficacy rate of 91.6 per cent in the interim analysis of the phase 3 clinical trial in Russia. In February 2021, Dr Reddy's applied for the emergency use of the Russian vaccine in India. Watch the video for more.Also Read: Russia's COVID-19 vaccine Sputnik V gets govt's nod


BusinessToday.In
April 12, 2021
Developed by Russia's Gamaleya national center of epidemiology and microbiology, Sputnik V is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin


BusinessToday.In
April 9, 2021
The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study.


BusinessToday.In
April 6, 2021
Share of the pharma firm rose 19.99% to Rs 220.85 against previous close of Rs 184.40 on BSE. The stock opened with a gain of 15.68% at Rs 212.90


Rashi Bisaria
New Delhi, April 6, 2021
COVID-19 vaccination: Uddhav Thackeray asks PM Modi to reduce eligible age to 25 yrsMaharashtra Chief Minister Uddhav Thackeray has written a letter to Prime Minister Narendra Modi asking to reduce the age for getting COVID-19 vaccination to 25 years. Saying that the second wave of the coronavirus is much stronger than the first wave in the state, Thackeray said Maharashtra is taking up vaccination at a rapid pace and is the number 1 state in the country in terms of COVID-19 vaccine doses adm...


PAGES 1 OF 7  12345